Prognostic Factors in Completely Resected Node-Negative Lung Adenocarcinoma of 3 cm or Smaller-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prognostic Factors in Completely Resected Node-Negative Lung Adenocarcinoma of 3 cm or Smaller

Published:2017-12 Issue:12 Volume:12 Page:1824-1833
ISSN:1556-0864
Container-title:Journal of Thoracic Oncology
language:en
Short-container-title:Journal of Thoracic Oncology

Author:

Hung Jung-Jyh,Yeh Yi-Chen,Wu Yu-Chung,Chou Teh-Ying,Hsu Wen-Hu

Funder

Ministry of Science and Technology

Taipei Veterans General Hospital

Taipei Veterans General Hospital-National Yang-Ming University-Excellent Physician Scientists Cultivation Program

Yen Tjing Ling Medical Foundation

Li-Yang Sheen Medical Education Memorial Foundation

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine,Oncology

Reference33 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J Clin,2015

2. Non-small cell lung cancer, version 6.2015;Ettinger;J Natl Compr Canc Netw,2015

3. The IASLC Lung Cancer Staging Project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer;Goldstraw;J Thorac Oncol,2016

4. Why do pathological stage IA lung adenocarcinomas vary from prognosis? A clinicopathologic study of 176 patients with pathological stage IA lung adenocarcinoma based on the IASLC/ATS/ERS classification;Zhang;J Thorac Oncol,2013

5. Comparison of malignant grade between pure and partially invasive types of early lung adenocarcinoma;Sasada;Ann Thorac Surg,2015

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Who benefit from adjuvant chemotherapy in stage I lung adenocarcinoma? A multi-dimensional model for candidate selection;Neoplasia;2024-04

2. Lung adenocarcinoma: selection of surgical approaches in solid adenocarcinoma from the viewpoint of clinicopathologic features and tumor microenvironmental heterogeneity;Frontiers in Oncology;2024-03-05

3. The value of high-risk clinicopathologic features for chemotherapy in stage I non-small cell lung cancer: a propensity score-matched study;Journal of Thoracic Disease;2024-03

4. Establishment and validation of nomograms for predicting survival of lung invasive adenocarcinoma based on the level of pathological differentiation: a SEER cohort-based analysis;Translational Cancer Research;2023-04

5. Comment on “Is It Time for a Specific Nodal Assessment for Every NSCLC Stage?”;Journal of Thoracic Oncology;2022-09

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3